Abstract
Lenalidomide Is a Highly Effective Maintenance Therapy in Myeloma Patients of All Ages; Results of the Phase III Myeloma XI Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1182/blood.v128.22.1143.1143
Journal: Blood | Publication Date: Dec 2, 2016 |
Citations: 25 |
Lenalidomide Is a Highly Effective Maintenance Therapy in Myeloma Patients of All Ages; Results of the Phase III Myeloma XI Study
Join us for a 30 min session where you can share your feedback and ask us any queries you have